is mounjaro a glp-1 receptor agonist How GLP‑1 Agonist? Exploring Its Role in Weight Loss Compare GLP-1 Options | Ozempic
Description
Lancet 405 , 627636 (2025)
There is no current evidence that retatrutide reduces cardiovascular events
Approved by the U.S
A planned part of the Phase 2 obesity trial looked at 98 participants who also had metabolic dysfunction-associated steatotic liver disease (MASLD, the condition formerly called non-alcoholic fatty liver disease)
Indias anti-obesity drug market, valued at USD 3.81 billion in 2023, is forecasted to reach USD 14.48 billion by 2033
